BrainsWay Company Description

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally.

It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases.

The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

BrainsWay Ltd.

Country	Israel
Founded	2003
Industry	Medical Devices
Sector	Healthcare
Employees	120
CEO	Hadar Levy

Contact Details

Address: 16 Hartum St Jerusalem, 9777516 Israel
Phone	972 2 582 4030
Website	brainsway.com

Stock Details

Ticker Symbol	BWAY
Exchange	Tel Aviv Stock Exchange
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	IL0011007189
SIC Code	3845

Key Executives

Name	Position
Hadar Levy	Chief Executive Officer
Dr. David Zacut M.D.	Co-Founder and Vice-Chairman
Avner Hagai	Founder and Director
Prof. Abraham Zangen Ph.D.	Co-Founder, Member of Scientific Advisory Board and Director
Ido Marom	Chief Financial Officer
Ross Mitchell	Vice President of Global Marketing
Michael Cohen	Vice President of US Sales
Dr. Yiftach Roth Ph.D.	Founder and Chief Scientific Officer
Dor Hagai	Vice President of Operations
Gilead Moiseyev Ph.D.	Chief Technology Officer